Journals / Türk Üroloji Dergisi/Turkish Journal of Urology / 2006 / Cilt: 32 - Sayı: 4

The management of mumps orchitis and infertility

Kabakulak orşiti, tedavisi ve infertilite

Pages
490–494
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further studies should be performed to improve the treatment of mumps orchitis, which has a considerable role in the etiology of infertility (5%).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Mumps is an acute viral infection, which is generally encountered among school-age children and young adults.
📊
Key Findings & Data:Incidence of mumps orchitis ranges between 5% and 37% and both testes are involved in 16% to 65% of the cases.
💡
Conclusion & Impact:Further studies should be performed to improve the treatment of mumps orchitis, which has a considerable role in the etiology of infertility (5%).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Kabakulak · Orşit · İnterferonlar

Abstract

Introduction: Mumps is an acute viral infection, which is generally encountered among school-age children and young adults. In postpubertal patients, its clinical course is more severe and may cause serious complications. Recently, with the widespread immunization programs during childhood, its prevalence has shifted towards adults. Epididymis and testis is the most common extraparotidal site for mumps infection in postpubertal males. Incidence of mumps orchitis ranges between 5% and 37% and both testes are involved in 16% to 65% of the cases. Rate of testicular atrophy following mumps orchitis is 40% to 70% and infertility ensues in 30% to 87% of the patients. Recently, interferon treatment for mumps orchitis has been reported to provide an earlier improvement in symptoms and decreased rate of atrophy and infertility. Further studies should be performed to improve the treatment of mumps orchitis, which has a considerable role in the etiology of infertility (5%).

Özet

Kabakulak, genellikle okul çağı çocuklarım ve genç erişkinleri tutan akut viral bir enfeksiyon olup özellikle puberte sonrası olgularda daha ağır seyreden ve istenmeyen yan etkilere neden olabilen bir hastalıktır. Son yıllarda aşılama programlarının daha yaygın uygulanması sonrasında erişkin yaştaki olgulara daha sık rastlanmaktadır. Epididimorşit postpubertal erkekte en sık görülen tükürük bezi dışı tutulum olup, görülme sıklığı %5-%37 arasındadır ve olguların %16-%65'inde her iki testis de tutulmaktadır. Testislerin tutulması sonrasında atrofı görülme oranı %40-%70 arasındadır ve olguların %30-%87' sinde infertilite gelişmektedir. Son yıllarda kabakulak orşiti tedavisinde interferon uygulanması ile akut belirtilerde daha erken iyileşme ve en aza indirgenmiş atrofı ve infertilite oranlan rapor edilmektedir. İnfertilite etiyolojisinde hatırı sayılır bir orana (%5) sahip olan kabakulak orşitinin tedavisi ile ilgili daha etkili yöntemlerin geliştirilmesi gerekmektedir.

🔖

Cite This Article

ADAYENER, C., AKYOL, İ., KADIOĞLU, A. (2006). The management of mumps orchitis and infertility. Türk Üroloji Dergisi/Turkish Journal of Urology, Cilt: 32 - Sayı: 4, 490–494. https://ajindex.com/articles/328385

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (19)

  1. Litman N, Baum SG: Mumps virus, Part III Infectious diseases and their etiologic agents Principles and Practice of Infectious Disease, Churchill Livingstone, 5th ed. Pp. 1496-1500, 1999
  2. Health Protection Agency: http://www.hpa.org.uk/in-fection/topicsaz/mumps/data.htm. Accessed July, 2005
  3. Freeman BA: Mumps virus. In: Textbook of Microbio¬logy, 21st ed. Philadelphia: W.B. Saunders Co., chapt, 39, 1001-1003, 1979
  4. Bertschat FL and Alexander M: Infertilitat nach Mumpsorchitis. Munch. Med. Wchnschr, 123: 606, 1981
  5. Niermann H: Infertilitat des Mannes nach Mumps-In-fektion ohne Mumps-Orchitis? Med. Welt, 31: 794, 1980
  6. Adamopoulos DA, Lawrence DM, Vassilopoulos P, et al: Pituitary-testicular interrelationships in mumps orchi¬tis and other viral infections. Brit. Med. J. 1: 1177, 1978
  7. Burhans RA: Treatment of mumps orchitis. J Urol 54: 547, 1945
  8. Nixon N, Lewis DB: Mumps orchitis surgical treatment. J Urol; 56: 554, 1946
  9. Lapides J, Herwig KR, Anderson E: Oxyphenbutasone therapy for mumps orchitis, acute epididymitis and ostei¬tis pubis. J Urol; 98: 528, 1967
  10. Bartak V: Sperm count, morphology and motility after unilateral mumps orchitis. J Reprod Fertil; 32: 491, 1973
  11. Beard CM, Benson RC Jr, Kelalis PP, et al: The inci¬dence and outcome of mumps orchitis in Rochester, Min¬nesota, 1935-1974. Mayo Clin Proc; 52: 3, 1977
  12. Ehrengut W, Schwartau M, Hubmann R: Testiculare Vorerkrankungen bei Patienten mit Hodentumoren unter besonderer Berücksichtigung der mumpsorchitis. Urologe A, 19:283, 1980
  13. Konig MP: Befund kleine Hoden. Schweiz Med; 117: 731, 1987
  14. Erpenbach KHJ: Systemic treatment with interferon alpha2B: An effective method to prevent sterility after bi¬lateral mumps orchitis. J Urol; 146: 54-56, 1991
  15. Rüther U, Stilz S, Röhl E: Successful interferon alp-ha2A therapy for a patient with acute mumps orchitis. Eur Urol; 27: 174-176,1995
  16. Baykal K, Şahin C, Başekim Ç: Kabakulak orşitinde interferon tedavisi: Klasik tedavi yöntemleriyle karşılaş¬tırma. Türk Üroloji Dergisi; 22: 59-62, 1996
  17. Başekim Ç, Kızılkaya F, Pekkafalı Z: Mumps epididy-morchitis: Sonography and color Doppler sonographic findings. Abd Imaging; 25: 322, 2000
  18. Ku JH, Kim YH, Jeon YS, et al: The preventive effect of systemic treatment with interferon-alpha2B for inferti¬lity from mumps orchitis. BJU Int; 84: 839-42, 1999
  19. Yeniyol CO, Sorguç S, Minareci S, et al: Role of inter¬feron alpha 2B in prevention of testicular atrophy w